← Back to Search

Other

REC-1245 for Cancer (No information Trial)

West Valley City, UT

Phase 1 & 2

Recruiting

Research Sponsored by Recursion Pharmaceuticals Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

Histologically-confirmed unresectable, locally advanced, or metastatic select solid tumors or select relapsed/refractory lymphoma

Must not have

Received treatment with another RBM39 degrader

Clinically significant gastrointestinal (GI) or GI malabsorption

Timeline

Screening 3 weeks

Treatment Varies

Follow Up initiation from study drug until disease progression [up to approximately 24 months]

Awards & highlights

No Placebo-Only Group

Summary

This trial will check if a new drug called REC-1245 is safe and effective when taken by mouth once a day by people with advanced solid tumors that cannot be removed by surgery.

See full description

Who is the study for?

This trial is for individuals with cancers that can't be removed by surgery, are locally advanced, or have spread to other parts of the body. It's open to those with primary cancer, oral and head & neck cancers, or lymphoma.Check my eligibility

What is being tested?

The study is testing REC-1245, a new medication given orally once daily. The goal is to assess its safety and how well it works in treating various advanced cancers.See study design

What are the potential side effects?

Specific side effects of REC-1245 aren't listed here but generally may include nausea, fatigue, allergic reactions or other symptoms depending on individual patient response.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

show original

Select...

My cancer is advanced and cannot be removed by surgery.

show original

Select...

I am fully active and can carry on all my pre-disease activities without restriction.

show original

Select...

My cancer can be measured by scans according to specific criteria.

show original

Select...

My cancer has worsened or returned after treatment, or I can't tolerate standard cancer treatments.

show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been treated with an RBM39 degrader before.

show original

Select...

I have serious stomach or nutrient absorption problems.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ initiation from study drug until disease progression [up to approximately 24 months]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~initiation from study drug until disease progression [up to approximately 24 months]

This trial's timeline: 3 weeks for screening, Varies for treatment, and initiation from study drug until disease progression [up to approximately 24 months] for reporting.